NO20084580L - Maleat ko-krystall av AZD1152 - Google Patents

Maleat ko-krystall av AZD1152

Info

Publication number
NO20084580L
NO20084580L NO20084580A NO20084580A NO20084580L NO 20084580 L NO20084580 L NO 20084580L NO 20084580 A NO20084580 A NO 20084580A NO 20084580 A NO20084580 A NO 20084580A NO 20084580 L NO20084580 L NO 20084580L
Authority
NO
Norway
Prior art keywords
azd1152
amino
maleate
crystal
ethyl
Prior art date
Application number
NO20084580A
Other languages
English (en)
Norwegian (no)
Inventor
Richard Anthony Storey
George Joseph Sependa
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36637528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084580(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20084580L publication Critical patent/NO20084580L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20084580A 2006-05-16 2008-11-03 Maleat ko-krystall av AZD1152 NO20084580L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0609621.8A GB0609621D0 (en) 2006-05-16 2006-05-16 Novel co-crystal
PCT/GB2007/001771 WO2007132227A1 (en) 2006-05-16 2007-05-14 Maleate co-crystal of azd1152

Publications (1)

Publication Number Publication Date
NO20084580L true NO20084580L (no) 2009-02-05

Family

ID=36637528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084580A NO20084580L (no) 2006-05-16 2008-11-03 Maleat ko-krystall av AZD1152

Country Status (22)

Country Link
US (1) US7625910B2 (enExample)
EP (1) EP2027114A1 (enExample)
JP (1) JP2009537498A (enExample)
KR (1) KR20090009297A (enExample)
CN (1) CN101448823A (enExample)
AR (1) AR060963A1 (enExample)
AU (1) AU2007251304A1 (enExample)
BR (1) BRPI0712791A2 (enExample)
CA (1) CA2650519A1 (enExample)
CL (1) CL2007001388A1 (enExample)
EC (1) ECSP088890A (enExample)
GB (1) GB0609621D0 (enExample)
IL (1) IL194862A0 (enExample)
MX (1) MX2008014550A (enExample)
NO (1) NO20084580L (enExample)
RU (1) RU2008149242A (enExample)
SA (1) SA07280243B1 (enExample)
TW (1) TW200813026A (enExample)
UA (1) UA95108C2 (enExample)
UY (1) UY30351A1 (enExample)
WO (1) WO2007132227A1 (enExample)
ZA (1) ZA200809172B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446093T1 (de) * 2001-12-24 2009-11-15 Astrazeneca Ab Substituierte chinazolin-derivate als aurora- kinase inhibitoren
CA2526285A1 (en) * 2003-05-15 2004-12-23 Arqule, Inc. Inhibitors of p38 and methods of using the same
CA2584368A1 (en) * 2004-10-19 2006-04-27 Arqule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
WO2007123892A2 (en) * 2006-04-17 2007-11-01 Arqule Inc. Raf inhibitors and their uses
CA2744713A1 (en) * 2008-12-05 2010-06-10 Arqule, Inc. Raf inhibitors and their uses
NZ598758A (en) * 2009-09-11 2013-12-20 Amgen Inc N-4 (-((3-(2-amino-4 pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer
GB201007286D0 (en) 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
GB201020179D0 (en) 2010-11-29 2011-01-12 Astex Therapeutics Ltd New compounds
GB201118656D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118654D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118675D0 (en) 2011-10-28 2011-12-14 Astex Therapeutics Ltd New compounds
GB201118652D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201209613D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201209609D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201307577D0 (en) 2013-04-26 2013-06-12 Astex Therapeutics Ltd New compounds
HUE034490T2 (en) 2013-09-16 2018-02-28 Astrazeneca Ab Therapeutic polymer nanoparticles and methods for their preparation and use
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
BR112016022056B1 (pt) 2014-03-26 2023-04-11 Astex Therapeutics Limited Combinação, composição farmacêutica, uso de uma combinação ou uma composição farmacêutica, e, produto farmacêutico
US10736900B2 (en) 2014-03-26 2020-08-11 Astex Therapeutics Ltd Combinations of an FGFR inhibitor and an IGF1R inhibitor
TWI719960B (zh) 2015-02-10 2021-03-01 英商阿斯迪克治療公司 新穎組成物
US10478494B2 (en) 2015-04-03 2019-11-19 Astex Therapeutics Ltd FGFR/PD-1 combination therapy for the treatment of cancer
HUE050567T2 (hu) 2015-09-23 2020-12-28 Janssen Pharmaceutica Nv Triciklusos heterociklusok rák kezelésére
WO2017050865A1 (en) 2015-09-23 2017-03-30 Janssen Pharmaceutica Nv Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446093T1 (de) * 2001-12-24 2009-11-15 Astrazeneca Ab Substituierte chinazolin-derivate als aurora- kinase inhibitoren
UA83814C2 (ru) * 2002-12-24 2008-08-26 Астразенека Аб Производные фосфонооксихиназолина и их фармацевтическое применение

Also Published As

Publication number Publication date
US20080045481A1 (en) 2008-02-21
UY30351A1 (es) 2008-01-02
GB0609621D0 (en) 2006-06-21
CA2650519A1 (en) 2007-11-22
ZA200809172B (en) 2009-12-30
SA07280243B1 (ar) 2010-12-01
KR20090009297A (ko) 2009-01-22
UA95108C2 (en) 2011-07-11
JP2009537498A (ja) 2009-10-29
IL194862A0 (en) 2009-08-03
US7625910B2 (en) 2009-12-01
BRPI0712791A2 (pt) 2012-09-04
WO2007132227A1 (en) 2007-11-22
CN101448823A (zh) 2009-06-03
MX2008014550A (es) 2008-11-27
EP2027114A1 (en) 2009-02-25
AR060963A1 (es) 2008-07-23
RU2008149242A (ru) 2010-06-27
AU2007251304A1 (en) 2007-11-22
CL2007001388A1 (es) 2008-01-18
ECSP088890A (es) 2008-12-30
TW200813026A (en) 2008-03-16

Similar Documents

Publication Publication Date Title
UA95108C2 (en) Maleate co-crystal of azd1152 and use thereof for the treatment of cancer
WO2007149395A3 (en) 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer
IL198979A (en) Enzyme inhibitors diacylglycerol o-acetyltransferase type 1
MA30053B1 (fr) Derives [4-(benzo[b]thiophen-2-yl)-pyrimidin -2-yl]-amine en tant qu'inhibiteurs de ikk-beta pour le traitement du cancer et de maladies inflammatoires .
NO20084631L (no) Fremgangsmate for dannelsen av pyrazolylaminoquinazolin deivater inneholdende en fosfat gruppe
EA201290952A1 (ru) Химические соединения
BR112012008073A2 (pt) compostos heterocíclicos como inibidores de janus quinase
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
TNSN08367A1 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
NZ585460A (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
WO2007137107A3 (en) Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
WO2007087231A3 (en) Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
MY149143A (en) Thiazole compounds as protien kinase b (pkb) inhibitors
NO20051189L (no) 1,3-diamino-2-hydroksypropan prodrogederivater
IL198226A0 (en) 2-[l-phenyl-5-hydroxy-4alpha-methyl
Fujishiro et al. Epidithiodiketopiperazine as a pharmacophore for protein lysine methyltransferase G9a inhibitors: reducing cytotoxicity by structural simplification
NO20070655L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
PE20081372A1 (es) COMPOSICION FARMACEUTICA QUE COMPRENDE 2-[4-(7-ETIL-5H-PIRROLO[2,3-b]PIRAZIN-6-IL)-FENIL]-PROPAN-2-OL COMO INHIBIDOR DE QUINASA
BR0316606A (pt) Derivados de aminoindazóis e sua utilização como inibidores de quinases
TW200801027A (en) Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
PT2404901E (pt) Derivados de 4-benzilamino-pirrolidina 1,2-dissubstituídos como inibidores de cetp úteis para o tratamento de doenças tais como a hiperlipidemia ou a arteriosclerose
MX2009011754A (es) Inhibidores de enzima de diacilglicerol o-aciltransferasa tipo 1.
WO2008054698A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
BRPI0517435A (pt) triazóis úteis como inibidores de proteìna cinase
WO2007121154A3 (en) Substituted benzothiazole kinase inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application